Minimally invasive treatment for BOO: Towards a new standard?

Poster Session 85

  • Location:
    Room Stockholm (Hall B2, level 0)
  • Chairs:
     C. Gratzke, Munich (DE)
     T.Y. Lee, Seoul (KR)
     G.Y. Robert, Bordeaux CEDEX (FR)
  • Aims and objectives of this session

    Recently a number of new methods for BOO removal have been evaluated. The session discusses if we are ready for them and which of them could possibly become a new standard?

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Two year results of the BPH6 trial: A multi-center, prospective, randomized study of the prostatic urethral lift (PUL) vs transurethral resection of the prostate (TURP)

By: Gratzke C.1, Barber N.J.2, Speakman M.J.3, Berges R.4, Wetterauer U.5, Greene D.6, Sievert K-D.7, Chapple C.R.8, Montorsi F.9, Patterson J.M.8, Fahrenkrug L.10, Schoenthaler M.5, Sønksen J.10

Institutes: 1LMU-Klinikum der Universität München, Dept. of Urology, Munich, Germany, 2Frimley Park Hospital NHS Foundation Trust, Dept. of Urology, Surrey, United Kingdom, 3Musgrove Park Hospital, Dept. of Urology, Taunton, United Kingdom, 4PAN Klinik Koln, Dept. of Urology, Koln, Germany, 5University Hospital Freiburg, Dept. of Urology, Freiburg, Germany, 6City Hospitals Sunderland, Dept. of Urology, Sunderland, United Kingdom, 7University Clinic of Lubeck, Dept. of Urology, Lubeck, Germany, 8Sheffield Teaching Hospitals NHS Foundation Trust, Dept. of Urology, Sheffield, United Kingdom, 9Instituto San Rafaele, Dept. of Urology, Milan, Italy, 10Herlev Hospital, Dept. of Urology, Herlev, Denmark

Four year results from the largest, prospective, randomized study of prostatic urethral lift (PUL)

By: Roehrborn C.1, Gange S.2, Shore N.3, Giddens J.4, Bolton D.5, Cowan B.6, Cantwell A.7, McVary K.8, Chin P.9, Te A.10, Gholami S.11, Rashid P.12, Moseley W.13, Tutrone R.14, Freedman S.15, Incze P.16, Coffield K.17, Borges F.18, Rukstalis D.19

Institutes: 1University of Texas Southwestern Medical Center, Dept. of Urology, Dallas, United States of America, 2Western Urological Clinic, Dept. of Urology, Salt Lake City, United States of America, 3Carolina Urologic Research Center, Dept. of Urology, Myrtle Beach, United States of America, 4Jonathan Giddens Medicine Professional Corporation, Dept. of Urology, Brampton, Canada, 5Austin Health, Dept. of Urology, Heidelberg, Australia, 6Urology Associates of Denver, Dept. of Urology, Englewood, United States of America, 7Advanced Urology Institute, Dept. of Urology, Daytona Beach, United States of America, 8Southern Illinois University School of Medicine, Dept. of Urology, Springfield, United States of America, 9Illawarra Urology, Dept. of Urology, Figtree, Australia, 10Weill Cornell Medical Center, Dept. of Urology, New York, United States of America, 11Urology Associates of Silicon Valley, Dept. of Urology, San Jose, United States of America, 12Urology Centre, Dept. of Urology, Port Macquarie, Australia, 13Genesis Research LLC, Dept. of Urology, San Diego, United States of America, 14Chesapeake Urology Research Associates, Dept. of Urology, Baltimore, United States of America, 15Sheldon J. Freedman, M.D., Ltd., Dept. of Urology, Las Vegas, United States of America, 16The Fe/Male Health Centres, Dept. of Urology, Oakville, Canada, 17Scott and White Healthcare, Dept. of Urology, Temple, United States of America, 18Pinellas Urology Inc., Dept. of Urology, St. Petersburg, United States of America, 19Wake Forest Baptist Health, Dept. of Urology, Winston Salem, United States of America

Combined urethral lift and resection of the prostate (CURP): A novel surgical treatment of LUTS secondary to benign prostatic enlargement with preservation of antegrade ejaculation

By: Schoenthaler M.1, Sievert K-D.2, Miernik A.1, Hein S.1, Kunit T.2, Wilhelm K.1

Institutes: 1University Medical Centre Freiburg, Dept. of Urology, Freiburg, Germany, 2Paracelsus Medical University Salzburg, Dept. of Urology, Salzburg, Austria

A randomized clinical trial comparing prostatic injection of botulinum neurotoxin type A (Botox®) to optimized medical therapy in patients with BPH-related LUTS: End-of-study results of the PROTOX trial

By: Delongchamps N.B.1, Descazeaud A.2, Benard A.3, Azzouzi R.5, Saussine C.6, De La Taille A.7, Desgrandchamp F.8, Faix A.9, Karsenty G.10, Georget A.3, Fourmarier M.11, Robert G.4

Institutes: 1Cochin Hospital, Paris Descartes University, Dept. of Urology, Paris, France, 2Limoges University Hospital, Dept. of Urology, Limoges, France, 3Bordeaux University Hospital, Clinical Epidemiology Unit, Bordeaux, France, 4Bordeaux University Hospital, Dept. of Urology, Bordeaux, France, 5Angers University Hospital, Dept. of Urology, Angers, France, 6Strasbourg University Hospital, Dept. of Urology, Strasbourg, France, 7Henri-Mondor Hospital, University Paris-Est, Dept. of Urology, Créteil, France, 8Saint Louis Hospital, Paris Diderot University, Dept. of Urology, Paris, France, 9Montpellier University Hospital, Dept. of Urology, Montpellier, France, 10Hôpital De La Conception, Marseille University, Dept. of Urology, Marseille, France, 11Centre Hospitalier Du Pays D’Aix, Dept. of Urology, Aix en Provence, France

Prostatic artery embolization vs conventional TUR-P in the treatment of benign prostatic hyperplasia: First results of a prospective, randomized non-inferiority trial

By: Abt D.1, Hechelhammer L.2, Müllhaupt G.1, Kessler T.3, Schmid H-P.1, Engeler D.S.1, Mordasini L.1

Institutes: 1Cantonal Hospital St. Gallen, Dept. of Urology, St. Gallen, Switzerland, 2Cantonal Hospital St. Gallen, Dept. of Radiology, St. Gallen, Switzerland, 3Balgrist University Hospital, Dept. of Neuro-Urology, Zürich, Switzerland

Prostatic artery embolization as an alternative treatment to remove catheter in patients with indwelling bladder catheter due to benign prostatic hyperplasia

By: Secco S.1, Barbosa F.2, Di Trapani D.1, Migliorisi C.2, Galfano A.1, Carnevale F.C.3, Rampoldi A.G.2, Bocciardi A.M.1

Institutes: 1Niguarda Ca’ Granda Hospital, Dept. of Urology, Milan, Italy, 2Niguarda Ca’ Granda Hospital, Dept. of Interventional Radiology, Milan, Italy, 3Univerisity of Sao Paulo Medical School, InRad Institute, Sao Paulo, Brazil

First experiences of prostatic artery embolization for large benign prostatic hyperplasia ahead of a prospective randomized controlled trial

By: Niklas C.1, Saar M.1, Schneider G.2, Siemer S.1, Buecker A.2, Stöckle M.1, Massmann A.2

Institutes: 1UKS Universitätsklinikum des Saarlandes, Dept. of Urology and Pediatric Urology, Homburg, Germany, 2UKS Universitätsklinikum des Saarlandes, Dept. of Diagnostic and Interventional Radiology, Homburg, Germany

Multicenter experience of a novel treatment for BPH; aquablation - image guided robot-assisted water-jet ablation of the prostate: 1 Year follow-up

By: Anderson P.1, Gilling P.2, Tan A.3

Institutes: 1The Royal Melbourne Hospital, Dept. of Urology, Parkville, Australia, 2Tauranga Hospital, Dept. of Urology, Tauranga, New Zealand, 3The Mount Hospital, Dept. of Urology, Perth, Australia

Is absorption of irrigation fluid a problem in thulium laser vaporization of the prostate? A prospective investigation using the expired breath ethanol test

By: Schwab C.1, Müllhaupt G.1, Mordasini L.1, Abt D.1, Engeler D.1, Gramann T.1, Lüthi A.2, Schmid H-P.1

Institutes: 1Kantonsspital St. Gallen, Dept. of Urology, St. Gallen, Switzerland, 2Kantonsspital St. Gallen, Dept. of Anesthesiology, St. Gallen, Switzerland

TES (thulium ejaculation sparing): Impact of thuvep/thuvap on sexual outcomes

By: Carmignani L., Vizziello D., Signorini C., Ratti D., Marenghi C., Finkelberg E., Nazzani S., Stubinski R., Casellato S., Picozzi S.

Institutes: Policlinico San Donato, Dept. of Urology, San Donato Milanese, Italy

Thulium laser enucleation (thulep) versus transurethral resection of the prostate in saline (turis): A randomized prospective trial to compare intra and early postoperative outcomes

By: Bozzini G.1, Taverna G.1, Seveso M.1, De Francesco O.1, Bono P.1, Buffi N.2, Guazzoni G.2, Provenzano M.3, Mandressi A.1

Institutes: 1Humanitas Mater Domini, Dept. of Urology, Castellanza, Italy, 2Humanitas Research Hospital, Dept. of Urology, Rozzano, Italy, 3Humanitas Research Hospital, Rozzano, Italy

Surgical treatment of benign prostatic obstruction – consecutive real life data of 2648 patients

By: Wölbling F., Brunken C., Gross A.J., Wülfing C., Bach T.

Institutes: Asklepios Hospitals Hamburg, Dept. of Urology, Hamburg, Germany

Effects of 5α-reductase inhibition on benign prostatic hyperplasia treated by photoselective vaporization prostatectomy with the 180 Watt GreenLight XPS laser system: Results from the GOLIATH population

By: Brassetti A.1, Bachmann A.2, Tubaro A.3, Barber N.4, D’Ancona F.5, Muir G.6, Witzsch U.7, Grimm M.O.8, Benejam J.9, Stolzenburg J.U.10, Riddick A.11, Pahernik S.12, Roelink J.13, Ameye F.14, Saussine C.15, Bruyere F.16, Loidl W.17, Larner T.18, Gogoi N.19, Hindley R.20, Muschter R.21, Thorpe A.22, Shrotri N.23, Graham S.24, Hamann M.25, Miller K.26, Schostak M.27, Capitan C.28, Knispel H.29, Thomas A.30

Institutes: 1Sant’andrea Hospital, “la Sapienza” University of Rome, Dept. of Urology, Rome, Italy, 2University Hospital Basel, University Basel, Dept. of Urology, Basel, Switzerland, 3Sant’Andrea Hospital, “la Sapienza” University of Rome, Dept. of Urology, Rome, Italy, 4Frimley Park Hospital, Dept. of Urology, Frimley, United Kingdom, 5Radboud University Njmegen Medical Centre, Dept. of Urology, Njmegen, The Netherlands, 6King’s College Hospital and King’s Health Partners, Dept. of Urology, London, United Kingdom, 7Krankenhaus Nordwest, Dept. of Urology, Frankfurt, Germany, 8University Hospital of Jena, Dept. of Urology, Jena, Germany, 9Hospital De Manacor, Dept. of Urology, Manacor, Spain, 10University of Leipzig, Dept. of Urology, Leipzig, Germany, 11NHS Lothian, Dept. of Urology, Eningurgh, United Kingdom, 12University Hospital of Heidelberg, Dept. of Urology, Heidelberg, Germany, 13Ziekenhuis Groep Twente, Dept. of Urology, Almelo/Hengelo, The Netherlands, 14AZ Maria Middelares Gent, Dept. of Urology, Ghent, Belgium, 15Nouvel Hopital Civil De Strasbourg, Strasbourg University, Dept. of Urology, Strasburg, France, 16CHRU Bretonneau, Dept. of Urology, Tours, France, 17Krankenhaus Der Barmherzigen Schwestern, Dept. of Urology, Linz, Australia, 18Brighton and Sussex University Hospitals NHS Trust, Dept. of Urology, Brighton, United Kingdom, 19Pinderfield Hospital Mid Yorkshire NHS Trust, Dept. of Urology, Wakefield, United Kingdom, 20Basingstoke and North Hampshire NHS Foundation Trust, Dept. of Urology, Hampshire, United Kingdom, 21Diakoniekrankenhaus Rotenburg, Dept. of Urology, Rotenburg, Germany, 22Freeman Hospital Newcastle, Dept. of Urology, Newcastle upon Tyne, United Kingdom, 23Kent and Canterbury Hospital, Dept. of Urology, Kent, United Kingdom, 24Whipps Cross University Hospital, Barth Health, Dept. of Urology, London, United Kingdom, 25Universitatsklinikum Schleswig-Holstein, Campus Kiel, Dept. of Urology, Kiel, Germany, 26Charite, Dept. of Urology, Berlin, Germany, 27University Hospital Magdeburg, Dept. of Urology, Magdeburg, Germany, 28Hospital Universitario Fundacion Alcorcon, Dept. of Urology, Madrid, Spain, 29Uro-Forschungs GmbH Im St. Hedwig Krankenhaus, Dept. of Urology, Berlin, Germany, 30Princess of Wales Hospital, Dept. of Urology, Bridgend, United Kingdom

Summary and context
 G.Y. Robert, Bordeaux CEDEX (FR)